# How Pharmacogenetic Testing Can Inform a Medication Plan

Learn how clinicians use pharmacogenetic results alongside treatment history, interactions, and follow-up—and why testing cannot guarantee a medication match.

Canonical page: https://sos-wellness.org/pharmacogenetic-testing-to-medication-plan-complete-workflow

Published by SOS Wellness. Updated: 2026-11-02.

![How Pharmacogenetic Testing Can Inform a Medication Plan](https://sos-wellness.org/assets/uploads/a9aea99a-7c03-4002-9cfc-47281907240f.webp)

Instead of carrying a genetic report between appointments and trying to interpret medication warnings yourself, use a clinician-led workflow to turn pharmacogenetic testing into a medication plan: define the treatment question, review relevant gene–drug guidance, agree on an action, and track your response. This guide explains what to prepare, which prescribing decisions results may inform, and the limits of testing.

## At a glance

- The pharmacogenetic testing to medication plan workflow requires a prescriber; a genetic report is not a prescription.
- SOS Wellness provides outpatient mental health care for Ohio individuals and families seeking psychiatric support.
- CPIC guidance helps clinicians interpret certain gene–drug results; it does not identify a universally best medication.
- Medication management still depends on symptoms, side effects, interactions, medical history, and follow-up.

## Why this matters

Pharmacogenetic testing examines inherited differences that can affect how your body processes or responds to certain medicines. A result can inform a specific prescribing decision, but it cannot diagnose a mental health condition or guarantee that a medication will work.

**The useful outcome is a documented treatment decision—not a report full of colored categories.** Your prescriber needs to connect the finding to the actual medication, the reason you take it, and your experience with treatment.

[SOS Wellness](https://sos-wellness.org/) provides psychiatry, medication management, therapy, addiction services, pharmacogenetic testing, and Ohio telehealth. Patients must be physically in Ohio during SOS telehealth visits. Confirm the available test and whether it fits your treatment question with the care team. **SOS provides outpatient care, not emergency response.** Discuss testing with your treating clinician before arranging a test or changing treatment.

## Before you start

- **Bring the right records.** Prepare a current medication list covering prescriptions, nonprescription medicines, and supplements. Include doses, actual use, previous medication trials, side effects, allergies, and the reason testing is being considered.
- **Confirm the clinical question and access.** Ask which prescribing decision the test would address, who will order it if appropriate, who will explain the result, and how the full report will reach your prescriber. Follow the laboratory’s collection instructions exactly.
- **Expect an interaction check even after testing.** Some interacting medicines can inhibit enzymes such as CYP2D6, making actual drug metabolism differ from the genetically predicted category. This is called phenoconversion; it does not mean your inherited genetic sequence has changed. Your clinician needs your medication list to interpret the result.

Before testing, discuss consent, who can access the result, and how the laboratory handles the sample and genetic information. Ask these questions before collection, not after the report arrives.

## Clinical question and treatment history

### Define the decision before ordering

1. **State the treatment question.** Ask whether a result could change the choice, dose, or monitoring of a particular medicine. Avoid treating testing as a general search for the perfect psychiatric medication.
2. **Record your treatment history.** Note what you took, why you stopped, whether symptoms improved, and which side effects occurred. Separate an allergic reaction from a medication that simply did not help.
3. **Choose a treatment target.** Describe an observable problem, such as panic interfering with work or difficulty maintaining a sleep routine. Agree on how you and your prescriber will assess improvement.
4. **Confirm clinical responsibility.** Identify the prescriber who will interpret the report and make any medication decision. If different clinicians prescribe different medicines, arrange communication between them.

**Expected result:** You can explain what question testing is meant to answer and who will act on the answer.

Testing is not a prerequisite for every medication decision. If the relevant medicine has no established actionable gene–drug guidance, the result does not automatically create a reason to change it. Your clinical history remains essential.

## Report verification and interpretation

### Connect the result to the actual medicine

1. **Verify identity and completeness.** Check 2 identifiers—your name and date of birth—against the report. Provide the full document rather than a screenshot of its summary page.
2. **Identify the reported finding.** Ask your clinician to explain the gene, the reported variants or alleles, and the predicted function or metabolism category. You do not need to interpret the notation yourself.
3. **Match the finding to the medication.** Have your prescriber distinguish established gene–drug recommendations from a laboratory’s broader ranking system. A color category is not a diagnosis or a stand-alone treatment instruction.
4. **Check clinical guidance and interactions.** Ask how the result fits the medicine’s labeling, relevant Clinical Pharmacogenetics Implementation Consortium guidance, and your other medicines.

**Expected result:** Your clinician can identify whether the finding changes a specific prescribing decision—and explain why or why not.

[CPIC’s gene–drug guidelines](https://www.clinpgx.org/cpic/guidelines) help clinicians use selected genetic results in prescribing. The FDA’s Table of Pharmacogenetic Associations lists selected gene–drug associations, but an association is not automatically an actionable prescribing recommendation. Inclusion does not mean everyone should be tested or that a dose should be changed. Neither resource replaces individual clinical assessment, and a commercial report should not be assumed to match every independent guideline.

A report has limits: testing does not predict every medication response or side effect. Ask which genes and variants the test covers and what it cannot detect; do not assume an unreported finding rules out every relevant genetic difference.

## Medication decision and written plan

### Turn interpretation into an agreed action

1. **Review the current response first.** Tell your prescriber what is helping, what is difficult, and whether you are taking the medicine as prescribed. A report alone is not a reason to stop an effective treatment.
2. **Agree on the action.** The decision might be to continue treatment, adjust a dose, choose a different medicine, or add monitoring. The appropriate action depends on the specific gene–drug finding and your clinical situation.
3. **Write down the instructions.** Record the medication name, dose, schedule, purpose, and any clinician-directed transition instructions. Ask the prescriber to clarify anything that conflicts with the dispensing label before taking it.
4. **Confirm the safety plan.** Identify which symptoms require a routine message, a prompt clinical call, or emergency help. Ask whom to contact outside normal appointment hours.

**Expected result:** You leave with a medication plan you can follow without interpreting the genetic report at home.

After your medication review, keep the genetic finding and the prescribing decision together in your records. A useful note explains the relevant result, the action taken, and the clinical reason—not simply that testing was completed.

**Never start, stop, skip, or change a prescribed dose based only on a report’s color or category.** Some medicines require a clinician-directed taper or other transition precautions.

## Follow-up and response tracking

### Check whether the plan helps

1. **Schedule follow-up before leaving.** Agree on the timing based on the medicine, your symptoms, and the change being made. Genetic results do not establish a universal follow-up interval.
2. **Keep a consistent record.** Track the treatment target, side effects, missed doses, and medication changes. Brief notes tied to dates are more useful than trying to reconstruct everything at the next visit.
3. **Report new medicines.** Tell your prescriber and pharmacist about additions or discontinuations, including nonprescription products. A new interaction can matter even though your inherited genetic result has not changed.
4. **Review benefit and tolerability together.** Bring your notes to the appointment and ask whether the plan should continue, change, or be reassessed for another reason.

**Expected result:** Your next decision reflects both the genetic information and what actually happened during treatment.

Keep a copy of the report and the latest medication instructions accessible for future care. Store genetic information securely and share it with clinicians through the communication method their practice recommends.

![Four steps connecting a clinical question to report review, a medication decision, and follow-up](https://sos-wellness.org/assets/uploads/762ff691-eb6d-40c6-88cc-490937adf7ee.webp)

A genetic result becomes useful when it connects to a prescribing decision and follow-up.

## A second workflow: review an existing result after a medication change

You do not necessarily need a new genetic test whenever treatment changes. Inherited results generally remain the same; the medication context and available interpretation can change.

Use the existing report as the starting point:

1. **Share the full report** with the clinician considering the new medicine.
2. **Update your medication list** to include recent additions, discontinuations, and actual use.
3. **Check the new gene–drug question** against current guidance rather than relying on an old summary category.
4. **Document the new decision** and its follow-up plan.

Ask the prescriber whether the original test covered the relevant gene and variants. Additional testing is a clinical question, not an automatic response to a new prescription.

This workflow is particularly useful when you change prescribers. The receiving clinician needs the underlying report and treatment history, not just a remembered description of the result.

## Which review fits your situation?

Both approaches below require clinical judgment. Pharmacogenetic information adds a particular kind of evidence; it does not replace ordinary medication management.

| Approach | Potential fit | Benefit | Limitation |
|---|---|---|---|
| Clinical medication review | Anyone starting, continuing, or reassessing treatment | Integrates symptoms, history, interactions, preferences, and side effects | Does not establish an inherited gene result |
| Pharmacogenetic-informed medication review | A specific prescribing question with relevant, actionable genetic guidance | Adds inherited information that can inform certain drug or dose decisions | Cannot predict overall treatment success or resolve every medication question |

**Choose the review around the prescribing question, not around the promise of a perfect medication match.** A clinical review remains necessary even when testing produces an actionable result.

SOS Wellness medication management belongs within this broader outpatient mental health care context: the treatment plan should address the person’s needs, not just a laboratory finding. Ask your treating clinician whether pharmacogenetic information would add useful evidence to your particular decision.

## Troubleshooting

### The report says caution, but the medication helps

**Do not stop it yourself.** Ask your prescriber whether the category reflects a dose consideration, a monitoring issue, or another type of concern. Review your actual benefit, side effects, dose, and relevant guidance together.

### Two reports appear to disagree

Bring both complete reports to your clinician. Ask whether differences in test coverage, reporting methods, or interpretation explain the apparent disagreement; comparing colors alone cannot resolve it. Ask whether a pharmacist or genetics professional should help clarify the findings.

### The report and your experience do not match

A genetically favorable category does not guarantee benefit or freedom from side effects. Ask for a clinical review of the treatment target, interactions, adherence, dose, and other possible explanations. Your experience is evidence, not something the report cancels out.

### The sample cannot be processed

Contact the ordering team or laboratory for its specific recollection instructions. Do not improvise collection or send a different specimen type. Continue following your existing treatment instructions unless your prescriber changes them.

### Symptoms worsen while you wait

Contact your treating clinician rather than waiting for the report to make a decision. **Call 911 for immediate danger or a medical emergency; call or text 988 for suicide or mental health crisis support.** Genetic testing is not emergency assessment or crisis treatment.

## Customize your workflow

Bring 3 questions to your next medication review: What decision would this result change? What would stay the same? How will we know whether the plan helps?

For children and teens, include the parent or guardian as appropriate while giving the young person room to describe symptoms and side effects. School observations can inform the clinical discussion, but they do not replace a diagnostic assessment or determine medication choice by themselves.

If several clinicians are involved, ask who maintains the current medication list and how changes will be shared. SOS Wellness provides both psychiatry and therapy; keep the purpose of each part of your care clear when discussing medication decisions.

### Explore your mental health care options

Learn about SOS Wellness outpatient mental health services in Ohio.

[Explore care options](<https://sos-wellness.org/>)

## FAQ

### How do I go from pharmacogenetic testing to a medication plan?

Have your prescriber connect the full report to a specific medication question, review interactions and treatment history, and document the decision. The plan also needs monitoring and follow-up instructions.

### Can a genetic test tell me the best antidepressant?

A genetic test cannot identify a guaranteed best antidepressant. Certain findings can inform particular drug or dose decisions, but symptoms, previous response, side effects, and other medicines still matter.

### Should I stop a medicine marked red on my report?

Do not stop or change a prescribed medicine based only on a report category. Ask your prescriber what the category means for your specific medicine, dose, and clinical response.

### Do I need another genetic test when my medication changes?

A medication change does not automatically require another genetic test. Your clinician should first check whether the existing report covers the relevant gene–drug question and remains interpretable using current guidance.

### Can other medicines affect how my genetic result is used?

Yes. Some medicines inhibit enzymes such as CYP2D6, so actual metabolism can differ from what the genetic result predicts without changing your inherited sequence. Give your prescriber and pharmacist a complete, current medication list so they can assess these interactions.

### Can pharmacogenetic testing diagnose ADHD or anxiety?

Pharmacogenetic testing does not diagnose ADHD or anxiety. Diagnosis requires a clinical assessment; genetic prescribing information addresses a different question.

### What should I bring to my medication review?

Bring the complete genetic report, your current medication list, previous treatment history, and notes about symptoms and side effects. Ask who will document the decision and when follow-up should happen.

## One last thing

**No medication change can be a useful outcome.** A careful review can confirm that the genetic finding does not justify changing a treatment that helps you, or that clinical factors outweigh a laboratory category.

The goal is not to make your prescription list match a report. It is to make a clear, safe decision you understand—and then check whether that decision improves your care.

## Further reading

- [MedlinePlus: Pharmacogenetic tests](https://medlineplus.gov/lab-tests/pharmacogenetic-tests/)

## Related reading

- [How Much Does Pharmacogenetic Testing Cost in Ohio?](https://sos-wellness.org/how-much-does-pharmacogenetic-testing-cost)
- [Pharmacogenetic Testing in Ohio: How to Choose an Option](https://sos-wellness.org/best-pharmacogenetic-testing-providers-in-ohio)
- [Pharmacogenetic testing](https://sos-wellness.org/pharmacogenetic-testing)